** Shares of major U.S. drugmakers rise between 2% and 3% in early trading amid a broader market selloff
** Johnson & Johnson JNJ.N rises 2.4% to $159.07, Merck MRK.N 2.2% to $88.33, AbbVie ABBV.N 2.5% to $210.28, Amgen AMGN.O 2.3% to $312.23
** The pharma sector ducked U.S. President Donald Trump's sweeping tariffs announced on Wednesday for now
** The news came as "a big positive to the (pharma) sector that has been under pressure from this for the last two weeks," UBS analysts said, adding that AbbVie and Merck, with significant ex-U.S. manufacturing, came out as "big winners"
** However, the administration's call for "robust and resilient domestic manufacturing" in the sector, suggests that it remained on its radar - UBS
** Up to last close, JNJ up 7.4%, AMGN up 17.3%, MRK down ~13%, ABBV up 15.5% so far this year
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.